Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

Details

Original languageEnglish
Pages (from-to)1187-1190
Number of pages4
JournalBlood advances
Volume2
Issue number11
Publication statusPublished - 12 Jun 2018
Peer-reviewedYes

External IDs

PubMed 29844203
ORCID /0000-0003-4340-9706/work/147143192

Keywords

ASJC Scopus subject areas

Library keywords